310-Helical Peptide Stabilization via Triazole Crosslinking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for stabilizing 310-helices in peptides often distort the helical conformation and lack effective thermal stabilization, while also having limited aqueous solubility, which hampers their utility in biologically relevant applications.
Innovation Solution
The use of a copper(I)-catalyzed azide-alkyne cycloaddition reaction to form a triazole-derived side chain-to-side chain crosslink in 310-helical peptides, which maintains the conformational integrity and enhances thermal stability and aqueous solubility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If conventional crosslinking methods (e.g., metathesis derived olefinic bridges) are used to stabilize 310-helices, then thermal stability is improved, but the backbone conformation is distorted and H-bonds are broken
Solution Approach 1:
The patent introduces a p-phenylenediacetic acid bridge as an intermediary crosslinking agent that connects side chains without directly distorting the backbone. This mediator allows thermal stabilization while preserving the native 310-helical conformation and intramolecular H-bonding pattern.
Solution Approach 2:
The crosslinking is performed locally at specific positions (i→i+3 or i→i+4) along the peptide chain, allowing stabilization of the helical structure without globally distorting the backbone conformation. The localized crosslinks maintain local H-bonding while providing overall thermal stability.
2Shape
If α,α-disubstituted amino acids (e.g., Aib, Api) are used to form crosslinked 310-helices, then helix regularity is improved, but the dihedral angles of neighbouring residues are distorted away from ideality
Solution Approach 1:
The patent uses proteinogenic amino acids with standard dihedral angles as the primary building blocks, avoiding the need for non-natural α,α-disubstituted amino acids. This approach maintains ideal dihedral angles while still achieving helix regularity through the crosslinking pattern and conformational constraints.
Solution Approach 2:
The patent changes the crosslinking strategy from using non-natural amino acids with fixed dihedral angles to using natural amino acids with flexible dihedral angles that can adopt ideal values. The crosslinking parameters (position, geometry) are optimized to maintain helix regularity without constraining dihedral angles.
3Reliability
If hydrocarbon stapling is used to stabilize α-helical peptides, then clinical potential is achieved, but application to 310-helical peptides is limited
Solution Approach 1:
The patent develops a universal crosslinking methodology using p-phenylenediacetic acid bridges that can be applied to both α-helical and 310-helical peptides. This multi-functional approach maintains the proven clinical potential of hydrocarbon stapling while extending versatility to 310-helical structures through appropriate positioning of crosslinks at i→i+3 or i→i+4 intervals.
4Stability of the object's composition
If side chain-to-side chain cyclization is used to stabilize 310-helices, then conformational stability is improved, but aqueous solubility decreases
Solution Approach 1:
The patent changes the chemical parameters of the crosslinking bridge from hydrophobic hydrocarbon staples to more hydrophilic p-phenylenediacetic acid bridges. This parameter change maintains conformational stability through crosslinking while improving aqueous solubility through the polar character and hydrogen-bonding capability of the diacetic acid groups.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in a conformationally stable 310-helical peptide with improved aqueous solubility and thermal stability, preserving the ideal helical conformation, making it suitable for biologically important recognition processes and therapeutic applications.
Implementation Method 1
The use of a copper(I)-catalyzed azide-alkyne cycloaddition reaction to form a triazole-derived side chain-to-side chain crosslink in 310-helical peptides
Implementation Method 2
The 310-helix is defined by intramolecular H-bonds between amino acid residues placed at positions i and i+3
Data Source
AI summary
A peptide which can adopt a 310-helical conformation in which the side chains of two amino acid residues in the peptide backbone are linked by a group comprising an aromatic 5-membered ring.